Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction

Journal of Molecular and Cellular Cardiology

Volumn 50, Issue 3, 2011, Pages 522-533

  Vilahur, Gemma ^a,b   Juan Babot, Oriol ^a   Peña, Esther ^a,b   Oñate, Blanca ^a   Casaní, Laura ^a,b   Badimon, Lina ^a,b,c  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Apoptosis; Fibrosis; Inflammation; Ischemia reperfusion; MTOR; TLR4

Indexed keywords

CASPASE; COLLAGEN TYPE 1; GELATINASE A; INTERFERON REGULATORY FACTOR 3; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; METALLOPROTEINASE; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN P53; S6 KINASE; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDITIS; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; FIBROBLAST; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HISTOPATHOLOGY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEUKOCYTE MIGRATION; MACROPHAGE MIGRATION; MOLECULAR BIOLOGY; MYOCARDIAL DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPERFUSION INJURY; TISSUE REPAIR; UPREGULATION;

ANIMALS; APOPTOSIS; COLLAGEN; FIBROBLASTS; FIBROSIS; IN SITU NICK-END LABELING; INFLAMMATION; LEUKOCYTES; MACROPHAGES; MATRIX METALLOPROTEINASE 2; MYELOID DIFFERENTIATION FACTOR 88; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; PROTO-ONCOGENE PROTEINS C-AKT; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SWINE; TOLL-LIKE RECEPTOR 4; TOR SERINE-THREONINE KINASES; TRANSFORMING GROWTH FACTOR BETA; VENTRICULAR REMODELING;

SUIDAE;

EID: 79551614815     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.12.021     Document Type: Article

References (44)

1. Pfeffer M.A., Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990, 81:1161-1172.
2. Gaudron P., Eilles C., Kugler I., Ertl G. Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors. Circulation 1993, 87:755-763.
3. Gajarsa J.J., Kloner R.A. Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities. Heart Fail Rev 2011, 16:13-21.
4. Kleinbongard P., Heusch G., Schulz R. TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure. Pharmacol Ther 2010, 127:295-314.
5. Hausenloy D.J., Yellon D.M. Time to take myocardial reperfusion injury seriously. N Engl J Med 2008, 359:518-520.
6. Logue S.E., Gustafsson A.B., Samali A., Gottlieb R.A. Ischemia/reperfusion injury at the intersection with cell death. J Mol Cell Cardiol 2005, 38:21-33.
7. Ovize M., Baxter G.F., Di Lisa F., Ferdinandy P., Garcia-Dorado D., Hausenloy D.J., et al. Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res 2010, 87:406-423.
8. Gottlieb R.A., Burleson K.O., Kloner R.A., Babior B.M., Engler R.L. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 1994, 94:1621-1628.
9. Eefting F., Rensing B., Wigman J., Pannekoek W.J., Liu W.M., Cramer M.J., et al. Role of apoptosis in reperfusion injury. Cardiovasc Res 2004, 61:414-426.
10. Yaoita H., Ogawa K., Maehara K., Maruyama Y. Apoptosis in relevant clinical situations: contribution of apoptosis in myocardial infarction. Cardiovasc Res 2000, 45:630-641.
11. Zhao Z.Q., Velez D.A., Wang N.P., Hewan-Lowe K.O., Nakamura M., Guyton R.A., et al. Progressively developed myocardial apoptotic cell death during late phase of reperfusion. Apoptosis 2001, 6:279-290.
12. Garcia-Dorado D., Ruiz-Meana M., Piper H.M. Lethal reperfusion injury in acute myocardial infarction: facts and unresolved issues. Cardiovasc Res 2009, 83:165-168.
13. Borutaite V., Jekabsone A., Morkuniene R., Brown G.C. Inhibition of mitochondrial permeability transition prevents mitochondrial dysfunction, cytochrome c release and apoptosis induced by heart ischemia. J Mol Cell Cardiol 2003, 35:357-366.
14. Sun Y. Myocardial repair/remodelling following infarction: roles of local factors. Cardiovasc Res 2009, 81:482-490.
15. Bramos D., Ikonomidis I., Tsirikos N., Kottis G., Kostopoulou V., Pamboucas C., et al. The association of coronary flow changes and inflammatory indices to ischaemia-reperfusion microvascular damage and left ventricular remodelling. Basic Res Cardiol 2008, 103:345-355.
16. Chorianopoulos E., Heger T., Lutz M., Frank D., Bea F., Katus H.A., et al. FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK. Basic Res Cardiol 2010, 105:301-313.
17. Vilahur G., Hernandez-Vera R., Molins B., Casani L., Duran X., Padro T., et al. Short-term myocardial ischemia induces cardiac modified C-reactive protein expression and proinflammatory gene (cyclo-oxygenase-2, monocyte chemoattractant protein-1, and tissue factor) upregulation in peripheral blood mononuclear cells. J Thromb Haemost 2009, 7:485-493.
18. Sipido K.R., Tedgui A., Kristensen S.D., Pasterkamp G., Schunkert H., Wehling M., et al. Identifying needs and opportunities for advancing translational research in cardiovascular disease. Cardiovasc Res 2009, 83:425-435.
19. Hausenloy D.J., Baxter G., Bell R., Botker H.E., Davidson S.M., Downey J., et al. Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations. Basic Res Cardiol 2010, 105:677-686.
20. Ibanez B., Prat-Gonzalez S., Speidl W.S., Vilahur G., Pinero A., Cimmino G., et al. Early metoprolol administration before coronary reperfusion results in increased myocardial salvage: analysis of ischemic myocardium at risk using cardiac magnetic resonance. Circulation 2007, 115:2909-2916.
21. Fishbein M.C., Meerbaum S., Rit J., Lando U., Kanmatsuse K., Mercier J.C., et al. Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J 1981, 101:593-600.
22. Lundberg K.C., Szweda L.I. Initiation of mitochondrial-mediated apoptosis during cardiac reperfusion. Arch Biochem Biophys 2004, 432:50-57.
23. Chandrashekhar Y., Sen S., Anway R., Shuros A., Anand I. Long-term caspase inhibition ameliorates apoptosis, reduces myocardial troponin-I cleavage, protects left ventricular function, and attenuates remodeling in rats with myocardial infarction. J Am Coll Cardiol 2004, 43:295-301.
24. Abbate A., Biondi-Zoccai G.G., Bussani R., Dobrina A., Camilot D., Feroce F., et al. Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure. J Am Coll Cardiol 2003, 41:753-760.
25. Heusch G., Boengler K., Schulz R. Cardioprotection: nitric oxide, protein kinases, and mitochondria. Circulation 2008, 118:1915-1919.
26. Hausenloy D.J., Yellon D.M. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res 2004, 61:448-460.
27. Vilahur G., Casani L., Pena E., Duran X., Juan-Babot O., Badimon L. Induction of RISK by HMG-CoA reductase inhibition affords cardioprotection after myocardial infarction. Atherosclerosis 2009, 206:95-101.
28. Skyschally A., van Caster P., Boengler K., Gres P., Musiolik J., Schilawa D., et al. Ischemic postconditioning in pigs: no causal role for RISK activation. Circ Res 2009, 104:15-18.
29. Musiolik J., van Caster P., Skyschally A., Boengler K., Gres P., Schulz R., et al. Reduction of infarct size by gentle reperfusion without activation of reperfusion injury salvage kinases in pigs. Cardiovasc Res 2010, 85:110-117.
30. Gustafsson A.B., Gottlieb R.A. Autophagy in ischemic heart disease. Circ Res 2009, 104:150-158.
31. Buss S.J., Muenz S., Riffel J.H., Malekar P., Hagenmueller M., Weiss C.S., et al. Beneficial effects of mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction. J Am Coll Cardiol 2009, 54:2435-2446.
32. Chong A.J., Shimamoto A., Hampton C.R., Takayama H., Spring D.J., Rothnie C.L., et al. Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart. J Thorac Cardiovasc Surg 2004, 128:170-179.
33. Takeishi Y., Kubota I. Role of Toll-like receptor mediated signaling pathway in ischemic heart. Front Biosci 2009, 14:2553-2558.
34. Hall G., Hasday J.D., Rogers T.B. Regulating the regulator: NF-kappaB signaling in heart. J Mol Cell Cardiol 2006, 41:580-591.
35. Nichols T.C., Bellinger D.A., Reddick R.L., Smith S.V., Koch G.G., Davis K., et al. The roles of von Willebrand factor and factor VIII in arterial thrombosis: studies in canine von Willebrand disease and hemophilia A. Blood 1993, 81:2644-2651.
36. Riad A., Jager S., Sobirey M., Escher F., Yaulema-Riss A., Westermann D., et al. Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in mice. J Immunol 2008, 180:6954-6961.
37. Birks E.J., Felkin L.E., Banner N.R., Khaghani A., Barton P.J., Yacoub M.H. Increased toll-like receptor 4 in the myocardium of patients requiring left ventricular assist devices. J Heart Lung Transplant 2004, 23:228-235.
38. Orn S., Manhenke C., Ueland T., Damas J.K., Mollnes T.E., Edvardsen T., et al. C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction. Eur Heart J 2009, 30:1180-1186.
39. Nijmeijer R., Krijnen P.A., Assink J., Klaarenbeek M.A., Lagrand W.K., Veerhuis R., et al. C-reactive protein and complement depositions in human infarcted myocardium are more extensive in patients with reinfarction or upon treatment with reperfusion. Eur J Clin Invest 2004, 34:803-810.
40. van Amerongen M.J., Harmsen M.C., van Rooijen N., Petersen A.H., van Luyn M.J. Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice. Am J Pathol 2007, 170:818-829.
41. Frantz S., Hu K., Adamek A., Wolf J., Sallam A., Maier S.K., et al. Transforming growth factor beta inhibition increases mortality and left ventricular dilatation after myocardial infarction. Basic Res Cardiol 2008, 103:485-492.
42. Lauten A., Majos E., Muhlich A., Wahlers T., Weider S., Fischer J.H., et al. Ischemia-reperfusion injury activates early extracellular matrix processing and expression of endostatin in the heart with differential effects of temperature. Basic Res Cardiol 2009, 104:559-569.
43. Kim S., Lee Y., Seo J.E., Cho K.H., Chung J.H. Caveolin-1 increases basal and TGF-beta1-induced expression of type I procollagen through PI-3 kinase/Akt/mTOR pathway in human dermal fibroblasts. Cell Signal 2008, 20:1313-1319.
44. Martin S.J., Reutelingsperger C.P., McGahon A.J., Rader J.A., van Schie R.C., LaFace D.M., et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 1995, 182:1545-1556.